Dietary caffeine consumption and withdrawal: Confounding variables in quantitative cerebral perfusion studies?

Radiology

Volumn 227, Issue 1, 2003, Pages 129-135

  Field, Aaron S ^a,b   Laurienti, Paul J ^a   Yen, Yi Fen ^a   Burdette, Jonathan H ^a   Moody, Dixon M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Brain, perfusion; Drugs, side effects; Magnetic resonance (MR), perfusion study

Indexed keywords

CAFFEINE; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; EVALUATION; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LINEAR REGRESSION ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WHITE MATTER;

CAFFEINE; CEREBROVASCULAR CIRCULATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; REGRESSION ANALYSIS; SINGLE-BLIND METHOD;

EID: 0037382039     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2271012173     Document Type: Article

References (31)

1. Phillis PW. Adenosine in the control of the cerebral circulation. Cerebrovasc Brain Metab Rev 1989; 1:26-54.
2. Gibbs FA, Gibbs EL, Lennon WG. Cerebral blood flow in man as influenced by adrenaline, caffeine, amyl nitrite and histamine. Am Heart J 1935; 10:916-924.
3. Mathew RJ, Barr DL, Weinman ML. Caffeine and cerebral blood flow. Br J Psychiatry 1983; 143:604-608.
4. Cameron OG, Modell JG, Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 1990; 47:1141-1146.
5. Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev 1999; 23:563-576.
6. Dager SR, Friedman SD. Brain imaging and the effects of caffeine and nicotine. Ann Med 2000; 32:592-599.
7. Smits P, Aengevaeren WR, Corstens FH, et al. Caffeine reduces dipyridamole-induced myocardial ischemia. J Nucl Med 1989; 30:1723-1726.
8. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990; 14:538-554.
9. Ogawa S, Lee T, Nayak AS, et al. Oxygen-sensitive contrast in magnetic resonance imaging of rodent brain at high magnetic fields. Magn Reson Med 1990; 14:68-78.
10. Parrish T, Mulderink T, Gitelman D, et al. Caffeine as a BOLD contrast booster. Presented at the Seventh Annual Meeting of the Organization for Human Brain Mapping, Brighton, England, June 10-14, 2001.
11. Mulderink TA, Gitelman DR, Mesulam MM, Parrish TB. On the use of caffeine as a contrast booster for BOLD fMRI studies. Neuroimage 2002; 15:37-44.
12. Laurienti PJ, Field AS, Burdette JH, Maldjian JA, Yen YF, Moody DM. Dietary caffeine consumption modulates fMRI measures. Neuroimage 2002; 17:751-757.
13. Laurienti PJ, Field AS, Burdette JH, Maldjian JA, Yen YF, Moody DM. The relationship between caffeine-induced changes in resting cerebral perfusion and BOLD signal. AJNR Amer J Neuroradiol (in press).
14. Arnaud MJ. The pharmacology of caffeine. Progr Drug Res 1987; 31:273-313.
15. Griffiths RR, Evans SM, Heishman SJ, et al. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990; 255:1123-1132.
16. Leonard TK, Watson RR, Mohs ME. The effects of caffeine on various body systems: a review. J Am Diet Assoc 1987; 87:1048-1053.
17. Bunker ML, McWilliams M. Caffeine content of common beverages. J Am Diet Assoc 1979; 74:28-32.
18. Yang Y, Frank JA, Hou L, et al. Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling. Magn Reson Med 1998; 39:825-832.
19. Yen YF, Field AS, Martin EM, et al. Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge. Magn Reson Med 2002; 47:921-928.
20. Shenkin HA. Effects of various drugs upon cerebral circulation and metabolism of man. J Appl Physiol 1951; 3:465-471.
21. Mathew RJ, Wilson WH. Caffeine consumption, withdrawal and cerebral blood flow. Headache 1985; 25:305-309.
22. Griffiths RR, Woodson PP. Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 1988; 94:437-451.
23. Couturier EGM, Laman DM, van Duijn MAJ, et al. Influence of caffeine and caffeine withdrawal on headache and cerebral blood flow velocities. Cephalgia 1997; 17:188-190.
24. Jones HE, Herning RI, Cadet JL, et al. Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology 2000; 147:371-377.
25. Edvinsson L, Owman C, Sjoberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels: a histochemical and pharmacological study. Brain Res 1976; 115:377-393.
26. Fastbom J, Pazos A, Probst A, Palacios JM. Adenosine A1-receptors in human brain: characterization and autoradiographic visualization. Neurosci Lett 1986; 65:127-132.
27. Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 1997; 27:322-335.
28. Jennings LL, Hao C, Cabrita MA, et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 2001; 40:722-731.
29. National Coffee Association of U.S.A. 2000 national coffee drinking trends, consumption patterns from 1960 to present. New York, NY: National Coffee Association of U.S.A., 2000.
30. Traversa U, Rosati AM, Florio C, et al. Effects of chronic administration of adenosine antagonists on adenosine A1 and A2a receptors in mouse brain. In Vivo 1994; 8:1073-1078.
31. Johansson B, Georgiev V, Lindstrom K, et al. A1 and A2a adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment. Brain Res 1997; 762:153-164.